Chronic Renal Failure (CRF) Risk factors Causes Stage CRF Treatment

Chronic Renal Failure (CRF) OR CRD/CKD

ChronicChronic Hepatitis Classification viral hepatitis Clinical features and Treatment. Read more ... » renalDiabetic Nephropathy and Renal complications of DM (Diabetes Mellitus). Read more ... » diseaseFILARIASIS Lymphatic Systems Disease Causes Diagnosis Signs and Symptoms with Treatment. Read more ... » is a destruction of neph­rons of the kidneys due to several causesFILARIASIS Lymphatic Systems Disease Causes Diagnosis Signs and Symptoms with Treatment. Read more ... ». The damage to renal structure and function is irr ­versib This results in uremia which leads to dysfunction of several organs.

Chronic kidneyDiabetic Nephropathy and Renal complications of DM (Diabetes Mellitus). Read more ... » disease (CKD) is defined as kidney damage or glomerular filtration rate (GFR) <60 mL/min/1.73 m2for >3 months.

The destruction of kidney is a chronic process of more than 3 months.

Stages of Chronic Renal Disease/Chronic Kid­ney Disease (CKD)

  • Stage 1
    • Kidney damage with normal or in­creased GFR – 90 ml/min/1.73 m2
  • Stage 2
    • Kidney damage with decreased GFR­60-89
  • Stage 3
    •  Moderately decreased GFR 30-59
  • Stage 4
    • Sftverely decreased GFR 15-29
  • Stage 5
    • Renal failure GFR < 15

Risk factors for CRD/CKD

Chronic Renal Failure (CRF)1

Chronic Renal Failure (CRF) Risk factors Causes Stage CRF Treatment

History of CRF

Common causes of chronic renal disease and presentations

Pregnancy Considerations in CRF

  • Renal function in CKD may deteriorate during pregnancy.
  • Creatinine >1.5 and hypertension are major risk factors for worsening renal function.
  • Increased risk of premature labor, preeclampsia, and/or fetal loss

Physical ExaminationHow to take good medical history & examination. Read more ... » in Chronic Renal Failure (CRF)

Genetics of CRF –

  • There may be a monogenic inheritance,
  • autosomal dominance or
  • polymorphism of ACE (Angiotensin Con­verting Enzyme) genes.

Cockcroft-Gault Equation for creatinine clear­ance

UREMIA IN CRF

  • Azotemia is retention of nitrogenous waste products due to renal insufficiency.
  • Uremia is progressive renal insufficiency with multi­organ involvement.
  • In uremia there is anorexia, malaise, vomiting, head­ache.
  • In uremia there is toxicity due to urea, urates, hippurates, polyamines, phenols, benzoates and in­doles.
  • As a result there is :
  • Anaemia Malnutrition
  • Impaired metabolism of carbohydrates, fats and proteins
  • Loss of energy Metabolic’ bone disease
  • Increased levels of :
  • Decreased levels of :
    • EPO – erythropoietin
    • 1,25, dihydroxycholecalciferol
  • Electrolyte abnormalities

Fluid, Electrolyte and Acid Base Disturbance Sodium and water

  • There is increase of sodium and water in the body.
  • There is sodium retention.
  • There is extracellular fluid volume expansion (ECFV).
  • Therefore, there is hyper­tension.
  • There is weight gain.
  • There is volume deple­tion only if there is vomiting, diarrhea, sweating, fe­ver or diuretic administration.

Treatment

  •  Diuretics – loop diuretics, metolazone ‘Q/ Restricted salt intake
  • Dialysis
  • For volume depletion – normal saline infusion

Potassium

Metabolic acidosis in CRF

Treatment of Hyperkalemia and Acidosis

  • Potassium binding resins
  • Restriction of potassium salts
  • Loop diuretics
  • For acidosis NAHC03 may be given if pH <7.35 .

Bone disease and Disorders of Calcium and Phos­phate

  • High bone turnover and high PTH levels result in sec­ondary hyperparathyroidism and osteitis fibrosa.
  • Low bone turnover and low PTH level result in osteo­malacia.
  • Decreased GFR causes decreased excretion of phos­phate and retention of phosphates.
  • This causes increased PTH and lowering of calcium, decrease of calcitriol resulting in hypocalcemia and bone diseases, osteomalacia, vitamin D deficiency, metabolic acidosis.
  • This causes bone pains, fractures, incapacity, diffi­culty in walking and movements.
  • Calciphylaxis is metastatic calcification of soft tissue and blood vessels.

Treatment

  • Calcitriol
  • Avoid aluminium compounds Calcium acetate
  • Calcium carbonate and Sodium phosphate binding agents.

Cardiovascular abnormalities in CRF

Treatment

  • For hypertension:
    • ACE I and ARB’s if serum crea­tinine less than three
    • Nifedipine, hydralazine, diltiazem, minoxidil.
  • For dyslipidemias :
    • Statins, gemfibrozil
  • For hyperhomocystinemia -
    • Vitamins, folate supplementation
  • Control of diabetes:
    • Metformin is not used Insulin levels are increased in CRD
  • For Pericarditis :
    • Dialysis, pericardiectomy, as­piration of fluid.

Hematological abnormalities Anaemia due to :

  • · Insufficient EPa (Erythropoietin)
  • · Iron and folate deficiency
  • · Hyperparathyroidism
  • · Chronic inf~ction
  • · Hemoglobinopathies
  • · Coagulation abnormalities
  • · Increased bleeding time
  • · Increased platelet aggregation
  • · Thromboembolic complications.

Treatment

  • EPa (Erythropoietin) is given 50-150 units /kg/ week subcutaneous
  • Side-effect of EPa – Hypertension, malignan­cies
  • Iron supplementation Vitamin BI2, folate Anticoag u lant prophylaxis.

Neuromuscular abnormalities in CRF

Gastrointestinal abnormalities in CRF

  • · Uremic fetor or odour or breath
  • · Gastritis
  • · Peptic disease
  • · Abdominal pain, nausea, vomiting
  • · Pancreatitis
  • · Anorexia
  • · Hiccups.

Endocrine and Metabolic disturbances

Dermatologic abnormalities

  • · Itching – Uremic pruritus
  • · Pallor – Skin necrosis

Management Treatment of CRD

  • · Control hypertension – ideal blood pressure 125/ 75
  • · Control diabetes – preprandial glucose 90 – 130 mg/dl and HBA1C level <7.2%
  • · Treat infections
  • · Avoid nephrotoxic drugs
  • · Estimation of plasma creatinine, GFR
  • · Management of electrolyte imbalance
  • · Management of acid-base disturbance
  • · Ultrasound for kidney size, renal masses
  • · Treat obstructive uropathy
  • · Voiding cystourethrography and management
  • · Renal biopsy and specific management
  • · Management of bleeding
  • · If kidney size <8.5 cm irreversibility of disease
  • · Protein restriction to 0.6 g/kg/day
  • · Dialysis
  • · Kidney transplantation.

Indications for Dialysis in CRF

  • Pericarditis
  • Neuropathy due to uremia
  • Encephalopathy
  • Muscle irritability
  • Anorexia, nausea, vomiting Fluid electrolyte abnormalities Severe volume overload Non-responsive hyperkalemia Progressive metabolic acidosis Asterixis
  • Serum creatnine >8 mg/dl.

Indications for Kidney transplantation in CRF

  • Irreversible ESRD (End Stage Renal Disease) Good antigenic match with donor
  • First degree relative donor
  • Primary transplantation.

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title="" rel=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>